Biocryst Pharmaceuticals buy Wedbush
Start price
30.06.25
/
50%
€7.60
Target price
30.06.26
€15.36
Performance (%)
14.00%
End price
01.07.26
€8.67
Summary
This prediction ended on 01.07.26 with a price of €8.67. The BUY prediction by Wedbush finished with a performance of 14.00%. Wedbush has a follow-up prediction for Biocryst Pharmaceuticals where he still thinks Biocryst Pharmaceuticals is a Buy. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biocryst Pharmaceuticals | 1.158% | 1.158% | 12.682% |
| iShares Core DAX® | 0,85 % | 0,39 % | 2,53 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % | 25,15 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % | 44,40 % |
| iShares S&P 500 | 0,06 % | 0,78 % | 20,95 % |
Comments by Wedbush for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its price target raised by analysts at Wedbush from $16.00 to $18.00. They now have an "outperform" rating on the stock.
Ratings data for BCRX provided by MarketBeat
In the thread Trading Biocryst Pharmaceuticals
Die von Wedbush gewählte maximale Laufzeit wurde überschritten
Current prediction by Wedbush for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€7.43
07.05.26
07.05.26
€17.86
07.05.27
07.05.27
15.98%
15:49
15:49
Stopped prediction by Wedbush for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€7.80
25.02.25
25.02.25
€14.28
25.02.26
25.02.26
-19.22%
26.02.26
26.02.26